Financials
- Market Capitalization 478.97 M
- Employee 67
- Founded 2012
- CEO N/A
- Website www.prothena.com
- Headquarter Ireland
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-11.8
ratio cours/chiffre d'affaires
8.07
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2937 | EDIT Editas Medicine, Inc. - Common Stock | 3.16 USD | -4.24% | +0.64% | +22.48% | +25.40% | 485.31 M USD | ||
| 2943 | EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -3.36% | +18.67% | -23.67% | 479.78 M USD | ||
| 2954 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.85 USD | -6.10% | -3.02% | +10.32% | +49.81% | 473.65 M USD | ||
| 2959 | PBYI Puma Biotechnology Inc - Common Stock | 9.06 USD | -1.95% | -2.58% | +13.53% | +79.41% | 467.68 M USD |